Journal:
:gene, cell and tissue
0
ebrahim eskandari-nasab genetic of non-communicable disease research center, zahedan university of medical sciences, zahedan, ir iran
fatemeh dahmardeh department of biology, faculty of sciences, university of zabol, zabol, ir iran
alireza rezaeifar department of clinical biochemistry, school of medicine, zabol university of medical sciences, zabol, ir iran; department of clinical biochemistry, school of medicine, zabol university of medical sciences, zabol, ir iran. tel: +98-5432253535, fax: +98-5432253537
tayebeh dahmardeh department of biology, faculty of sciences, ferdowsi university of mashhad, mashhad, ir iran
conclusions since telomerase is expressed in 90% of cancer cells, its inhibition can be considered as a goal of cancer treatment. results about 90% of cancers need a high level of this enzyme to continue cell multiplication. since this enzyme set is absent in normal cells, or present at a very low level, use of telomerase inhibitors cannot have significant effects on normal cells. evidence acqu...